Studies also demonstrated that AD-MSCs promoted angiogenesis in ischemic heart and cerebral diseases and peripheral vascular disease, via secreting angiogenic factors including VEGF, bFGF, IL-6, and transforming growth factor α (TGF-α) [32, 33]. This evidence concerns the gene TGFA and vascular disorder.